Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models

por Passer, Brent J., Cheema, Tooba, Wu, Shulin, Wu, Chen-lee, Rabkin, Samuel D., Martuza, Robert L.
Publicado 2012